Natarajan Rajagopalan

Person

Phoenixville, PA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Method of preparing nanoparticle compositions containing charged ph...
- Patent number 5,470,583
- Issue date Nov 28, 1995
- Eastman Kodak Company
- George C. Na
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of making nanoparticulate X-ray blood pool contrast agents u...
- Patent number 5,447,710
- Issue date Sep 5, 1995
- Eastman Kodak Company
- George C. Na
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of purified surface modifiers to prevent particle aggregation d...
- Patent number 5,352,459
- Issue date Oct 4, 1994
- Sterling Winthrop Inc.
- Kenneth R. Hollister
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of non-ionic cloud point modifiers to minimize nanoparticle agg...
- Patent number 5,346,702
- Issue date Sep 13, 1994
- Sterling Winthrop Inc.
- George C. Na
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of charged phospholipids to reduce nanoparticle aggregation
- Patent number 5,336,507
- Issue date Aug 9, 1994
- Sterling Winthrop Inc.
- George C. Na
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Formulations for nanoparticulate x-ray blood pool contrast agents u...
- Patent number 5,326,552
- Issue date Jul 5, 1994
- Sterling Winthrop Inc.
- George C. Na
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of ionic cloud point modifiers to prevent particle aggregation...
- Patent number 5,298,262
- Issue date Mar 29, 1994
- Sterling Winthrop Inc.
- George C. Na
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Natarajan Rajagopalan

Person

Patents Grantslast 30 patents

Method of preparing nanoparticle compositions containing charged ph...

Method of making nanoparticulate X-ray blood pool contrast agents u...

Use of purified surface modifiers to prevent particle aggregation d...

Use of non-ionic cloud point modifiers to minimize nanoparticle agg...

Use of charged phospholipids to reduce nanoparticle aggregation

Formulations for nanoparticulate x-ray blood pool contrast agents u...

Use of ionic cloud point modifiers to prevent particle aggregation...